Richmond Pharmacology is excited to announce that Dr. Jörg Taubel, Dr.Ulrike Lorch, Nobuo Ittetsu, and Minoru Takada will be attending BioJapan 2024in Yokohama. As Asia’s premier partnering event for the global biotechnologyindustry, BioJapan offers an unparalleled opportunity to engage with leaders inlife sciences, explore new business opportunities, and discuss the latestinnovations in biotechnology. The event will feature networking sessions,exhibitions, and one-on-one partnering meetings, making it a crucial gatheringfor industry professionals.
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
.svg){kind=small}
.avif)
